Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use

British Journal of Haematology

Volumn 114, Issue 3, 2001, Pages 671-680

  Coronel, Agnès ^a   Boyer, Aurélie ^a,b   Franssen, Jean Denis ^c,d   Romet Lemonne, Jean Loup ^e   Fridman, Wolf Herman ^a   Teillaud, Jean Luc ^a,f  

^a INSTITUT CURIE   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c BioSource Europe SA   (Belgium)

^d Euroscreen SA   (Belgium)

^e Immuno Designed Molecules   (France)

^f INSERM   (France)

Author keywords

Cellular therapy; Cytokine; Dendritic cells; Macrophages; T cells

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; COLECALCIFEROL; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KILLER CELL; MACROPHAGE; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

24,25-DIHYDROXYVITAMIN D 3; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-13; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034796791     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02982.x     Document Type: Article

References (49)

1. Functional diversity of helper T lymphocytes
2. Dendritic cells and the control of immunity
3. Cellular vaccines
4. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
5. Dendritic cells
6. Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties
7. The macrophage capacity for phagocytosis
8. Biosynthesis and posttranslational regulation of human IL-12
9. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
10. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
11. Origin, maturation and antigen presenting function of dendritic cells
12. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
13. Molecular cloning of the interleukin-1 beta converting enzyme
14. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level
15. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation
16. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon maturation, is transiently expressed in MHC class II compartment
17. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
18. The IL-12 p40 homodimer as a specific antagonist of the IL-12 heterodimer
19. Dendritic cells hold promise for immunotherapy
20. Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients
21. Dendritic cells: Unique leukocyte populations which control the primary immune response
22. In vivo production and function of IL-12 p40 homodimers
23. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells
24. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
25. Development of TH1, CD4+ T cells through IL-12 produced by Listeria-induced macrophages
26. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
27. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
28. Kinetics of dendritic cell activation: Impact on priming of Th1, Th2 and nonpolarized T cells
29. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity
30. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells
31. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34 (+) hematopoietic progenitor cells
32. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells
33. Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment
34. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
35. Cytokines induce the development of functionally heterogeneous T helper cell subsets
36. Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: Comparison with bone marrow CD34+ cells
37. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
38. Proliferating dendritic cell progenitors in human blood
39. Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells
40. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit
41. High-level IL-12 production by human dendritic cells requires two signals
42. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes
43. In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy
44. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
45. A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): Characterization and use in various assays
46. Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides
47. Reduced T helper 1 responses in IL-12 p40 transgenic mice
48. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
49. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells